India’s push to become self-reliant in pharmaceutical manufacturing has gained strong momentum under the Bulk Drug Park Scheme, a flagship initiative aimed at reducing dependence on imports of active pharmaceutical ingredients (APIs) and key starting materials. Approved by the Union Cabinet in March 2020, the scheme focuses on building world-class…
RamRajya News
Heralding RamRajya in Bharat